Objectives: This study aimed to identify, measure and evaluate expected costs of innovative palonosetron-based antiemetic therapy versus ondansetron-based treatment, the ultimate aim being to ...
This makes the use of CEA inappropriate. [21] For this reason, a cost analysis of palonosetron versus ondansetron was conducted. Furthermore, the clinical superiority of palonosetron in preventing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback